Focus: ExThera Medical is a public biotechnology company specializing in blood filtration technologies and therapies across infectious diseases, cardiovascular, oncology, ophthalmology, and nephrology. Founded in 2007 and headquartered in Martinez, CA, the company operates at the intersection of device-based therapeutics and drug development.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Best suited for early-career clinical operations professionals seeking meaningful device-drug experience in niche therapeutic areas, but limited roles and unclear pipeline momentum present constrained long-term growth prospects.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for ExThera Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from ExThera Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
EP2 receptor agonist approved for glaucoma and ocular hypertension with 15+ years of patent protection; primary revenue driver.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo